Free
All Subscriber Access
BiQ: FDA Approves CARDAMYST for the Treatment of PSVT (MIST)
BiQ: New Live BiQ Active Portfolio, BiQ Cheat Sheets, and Membership Plans for 2026
BiQ: A few final thoughts about Medicenna--for now. 12/10/25 (MDNAF)
BiQ: The Ziftomenib-Revumenib Debate 12/10/25 (KURA, SNDX)
BiQ: BiQ Annual Subscription Pricing
BiQ: Discontinuing Support for the BiQ Public Chat Server
BiQ: 11/25/25 Additional Thoughts on Capricor (CAPR)
BiQ: 11/25/25 The Deramiocel Debate (CAPR)
BiQ: 11/23/25 Quick Update on NeuroPace (NPCE)
BiQ: 11/23/25 Lyell Immunopharma Upcoming Catalysts (LYEL)